Role of kappa-opioid receptors in the effects of salvinorin A and ketamine on attention in rats - Wikidata - thesis-toulmin - TriplyDB

Role of kappa-opioid receptors in the effects of salvinorin A and ketamine on attention in rats

Role of kappa-opioid receptors in the effects of salvinorin A and ketamine on attention in rats

http://www.wikidata.org/entity/Q33848200

about

Kappa Opioids, Salvinorin A and Major Depressive Disorder Corticotropin-releasing factor (CRF)-induced disruption of attention in rats is blocked by the κ-opioid receptor antagonist JDTic.Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A Convergent pharmacological mechanisms in impulsivity and addiction: insights from rodent models.Learning and memory impairment induced by salvinorin A, the principal ingredient of Salvia divinorum, in wistar rats.The uncompetitive N-methyl-D-aspartate antagonist memantine reduces binge-like eating, food-seeking behavior, and compulsive eating: role of the nucleus accumbens shell.Comparative effects of different test day challenges on performance in the 5-choice serial reaction time task.Salvinorin A produces cerebrovasodilation through activation of nitric oxide synthase, κ receptor, and adenosine triphosphate-sensitive potassium channel.Sex differences in U50,488H-induced phosphorylation of p44/42 mitogen-activated protein kinase in the guinea pig brain.Relative Timing Between Kappa Opioid Receptor Activation and Cocaine Determines the Impact on Reward and Dopamine Release The uncompetitive NMDA receptor antagonists ketamine and memantine preferentially increase the choice for a small, immediate reward in low-impulsive rats Development of κ opioid receptor antagonists.Dissociable effects of kappa-opioid receptor activation on impulsive phenotypes in wistar rats.Determination of in vivo Bmax and Kd for 11C-GR103545, an agonist PET tracer for κ-opioid receptors: a study in nonhuman primates 4β-Methyl-5-(3-hydroxyphenyl)morphan opioid agonist and partial agonist derived from a 4β-methyl-5-(3-hydroxyphenyl)morphan pure antagonist The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.Salvia divinorum: from Mazatec medicinal and hallucinogenic plant to emerging recreational drug.Ketamine: promising path or false prophecy in the development of novel therapeutics for mood disorders?Exposure to Ketamine Anesthesia Affects Rat Impulsive Behavior.Inhibition of GABA synthesis in the prefrontal cortex increases locomotor activity but does not affect attention in the 5-choice serial reaction time task Kappa Opioid Receptor Activation in Dopamine Neurons Disrupts Behavioral Inhibition.Pituitary Adenylate Cyclase-Activating Polypeptide Disrupts Motivation, Social Interaction, and Attention in Male Sprague Dawley Rats.Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms.

P2860

Q28075656-5C6BC484-E2D9-4B0B-8206-184F7714E022 Q30446679-159A3141-1F55-4737-B984-AAFA07D64448 Q30467220-E4957A8D-4C95-4875-9B40-1E490CF61CAB Q34407185-922428AF-FB34-4B74-93E3-0CBFB5002DC8 Q34632744-C5C3224C-457F-4A6C-8732-74BB1A24A7EC Q35200006-9250E090-76F1-4175-9059-A3195816C5B9 Q35275505-38F5A06B-8EE0-4902-8E17-975F5F259F1D Q36069379-43C343C4-837C-4B52-9C03-60E902A005F8 Q36337475-601CACE3-8A23-40A5-872B-4A76DC84A10C Q36565615-EB2D65D5-33DF-48D0-9229-0397947701BB Q36609406-222F2E08-CFDE-4746-A287-89BA72D85033 Q36728154-B6EE80B4-E03E-4382-B997-58BC467EE19B Q37172767-09C305AD-2CD8-43E4-9813-B82871E63CE4 Q37177769-064BE371-666E-44BF-A4FA-E4405844B7AA Q37483722-BB43FFA1-9E05-4C12-8E82-741F3999120B Q37946259-8B1625F6-DFAA-4BA6-8E3C-B92945956D9E Q38116484-75603F97-9BB2-40ED-95B5-611D2E9852A3 Q38254452-5FBE8036-FC0B-4A66-BEEA-151F735408FF Q42364153-8E3053CF-217D-46E1-87F5-BBC523ECA810 Q42409166-9DE8ECCA-80CA-4996-9E50-9D8A6C843C1D Q44346829-DFC63FD9-1DC0-40F6-901B-DF2D13822AAF Q46241606-7E2BF653-A827-4CA7-BA9D-73458DC439B8 Q55438088-374ABCB0-05E5-47F4-A8B2-EC4A77DCAF36

P2860

Role of kappa-opioid receptors in the effects of salvinorin A and ketamine on attention in rats

http://www.wikidata.org/entity/Q33848200

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Role of kappa-opioid receptors ...... ketamine on attention in rats

@ast

Role of kappa-opioid receptors ...... ketamine on attention in rats

@en

type

label

Role of kappa-opioid receptors ...... ketamine on attention in rats

@ast

Role of kappa-opioid receptors ...... ketamine on attention in rats

@en

prefLabel

Role of kappa-opioid receptors ...... ketamine on attention in rats

@ast

Role of kappa-opioid receptors ...... ketamine on attention in rats

@en

P1433

Q33848200-522FC2CE-3550-4B7E-A757-06742FC68426

P1476

Q33848200-DBB3D29E-6B1B-4C22-A1FD-81BD7CA98BA4

P2093

Q33848200-145BBDBC-8D82-4831-AF40-B897ACC9D84D

Q33848200-46FBA675-5944-4325-ACBF-B5071216365E

Q33848200-773356B1-A20C-4F49-9A28-45AE0B9B779A

Q33848200-7B8006A8-5E98-4524-9298-152A5A87C7E8

Q33848200-92A75CED-21B9-4998-B200-0E75F55C2C72

Q33848200-A120110A-10D5-4724-A7B3-1D5D9D93C341

Q33848200-C6E03D09-60BC-4854-A53B-E96E245122CF

Q33848200-E6CB15B5-D1F9-46FC-8ED3-B717482A55AC

P2860

Q33848200-0D53D0E2-984A-4FA0-BBC9-BB128738C0B9

Q33848200-150A2B19-4D45-4E82-9E18-DD5FCFB41393

Q33848200-15B49D5B-6BA7-4A69-B886-0F2015EBF5F1

Q33848200-1918E565-69F9-44EB-A657-2E79755F71B2

Q33848200-1A9DE0C5-A093-4FBE-A558-F035A9C10AF4

Q33848200-1D875D84-41AC-4EA9-BD63-FF46F8521ED5

Q33848200-244DA482-7925-47B2-B8BA-C86A86D726AE

Q33848200-2F636356-3718-4214-818D-22C93C57002D

Q33848200-2FEE6A9A-51DE-4310-BB32-04D45C8BD784

Q33848200-3151CF87-589F-487B-9964-79C76A11E9D5

P2888

Q33848200-0356CCE6-20F0-41BB-A7DF-3A36E32A8723

P304

Q33848200-686A24F8-C07C-45B4-87A1-ADF5CEB59C00

P31

Q33848200-AFE6F8C9-E043-4557-890A-63BEBF700019

P356

Q33848200-6AA9370F-A679-414A-B70B-AE0C34805EB0

P433

Q33848200-8D5894B9-1A17-4410-87BE-323F0564ABC9

P478

Q33848200-553634A8-7A96-4F44-ADB3-99AAC36FA758

P577

Q33848200-A443D3D9-ACA1-44E3-86CB-C5A7360E1CBA

P5875

Q33848200-73CD400F-979F-4F44-9714-3D89A4B68DC0

P6179

Q33848200-16E5D390-A81B-4674-89CA-E6C2CA499717

P698

Q33848200-2D54F953-7AC6-4D86-9B64-8292E878FAF9

P921

Q33848200-97646048-907d-46c3-97a4-decbb10f5b67

Q33848200-AED9DEE0-A42A-492F-AF5D-12D939BF465B

P932

Q33848200-13E30B16-5FAA-4BAA-9428-2A1CB871EDF3

P356

S00213-010-1834-7

P1433

Psychopharmacology

P1476

Role of kappa-opioid receptors ...... ketamine on attention in rats

@en

P2093

Bruce M Cohen

http://www.w3.org/2001/XMLSchema#string

Bryan L Roth

http://www.w3.org/2001/XMLSchema#string

Christina L Nemeth

http://www.w3.org/2001/XMLSchema#string

Cécile Béguin

http://www.w3.org/2001/XMLSchema#string

F Ivy Carroll

http://www.w3.org/2001/XMLSchema#string

Joseph E Rittiner

http://www.w3.org/2001/XMLSchema#string

Tracie A Paine

http://www.w3.org/2001/XMLSchema#string

William A Carlezon

http://www.w3.org/2001/XMLSchema#string

P2860

Dopamine and reward: The anhedonia hypothesis 30 years on

Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist

Structure-based design, synthesis, and biochemical and pharmacological characterization of novel salvinorin A analogues as active state probes of the kappa-opioid receptor

Dynorphin, stress, and depression

NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development

U50,488, a kappa opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of rats

Salvinorin A, an active component of the hallucinogenic sage salvia divinorum is a highly efficacious kappa-opioid receptor agonist: structural and functional considerations

Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats

Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects

Psychotomimesis mediated by kappa opiate receptors

P2888

s00213-010-1834-7

P304

263-274

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00213-010-1834-7

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

210

http://www.w3.org/2001/XMLSchema#string

P577

2010-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

42807822

http://www.w3.org/2001/XMLSchema#string

P6179

1010971819

http://www.w3.org/2001/XMLSchema#string

P698

20358363

http://www.w3.org/2001/XMLSchema#string

P921

P932

2869248

http://www.w3.org/2001/XMLSchema#string